363 related articles for article (PubMed ID: 31182138)
1. The seemingly innocuous presentation of metastatic pancreatic tail cancer: a case report.
Rahman M; Washington L
J Med Case Rep; 2019 Jun; 13(1):178. PubMed ID: 31182138
[TBL] [Abstract][Full Text] [Related]
2. Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX.
Kao CT; Aziz M; Kasi A
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30173133
[TBL] [Abstract][Full Text] [Related]
3. Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis.
Bozkurt Duman B; Çil T
J Oncol Pharm Pract; 2020 Oct; 26(7):1738-1742. PubMed ID: 32070199
[TBL] [Abstract][Full Text] [Related]
4. Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
Yu K
Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):9-10. PubMed ID: 30807562
[No Abstract] [Full Text] [Related]
5. Endoscopic drainage for management of infected necrosis following EUS-TA in a patient with pancreatic cancer: A case report.
Kim YJ; Cho E; Park CH
Medicine (Baltimore); 2021 Apr; 100(16):e25466. PubMed ID: 33879679
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment for locally advanced pancreatic cancer.
Das M
Lancet Oncol; 2019 Jul; 20(7):e351. PubMed ID: 31178373
[No Abstract] [Full Text] [Related]
7. [Pure laparoscopic DP-CAR procedure with portal vein resection].
Voskanyan SE; Shabalin MV; Artemiyev AI; Kolyshev IY; Bogoevich Z; Kucherov NN; Bashkov AN; Naydenov EV
Khirurgiia (Mosk); 2019; (9):93-98. PubMed ID: 31532174
[TBL] [Abstract][Full Text] [Related]
8. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX.
Ozaki K; Hayashi H; Ikuta Y; Masuda T; Akaboshi S; Ogata K; Matumoto K; Ogawa K; Kamio T; Baba H; Takamori H
Clin J Gastroenterol; 2019 Dec; 12(6):603-608. PubMed ID: 30993652
[TBL] [Abstract][Full Text] [Related]
9. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.
Shimmura H; Kuramochi H; Jibiki N; Katagiri S; Nishino T; Araida T
Jpn J Clin Oncol; 2019 Dec; 49(11):1049-1054. PubMed ID: 31612916
[TBL] [Abstract][Full Text] [Related]
10. Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma.
Patil NR; Khan GN
Am J Case Rep; 2020 Jul; 21():e923803. PubMed ID: 32658872
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Pancreatic Carcinoma and Experience with FOLFIRINOX - a Cross Sectional Analysis From a Developing Country.
Zahir MN; Jabbar AA
Asian Pac J Cancer Prev; 2015; 16(14):6001-6. PubMed ID: 26320487
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Nywening TM; Wang-Gillam A; Sanford DE; Belt BA; Panni RZ; Cusworth BM; Toriola AT; Nieman RK; Worley LA; Yano M; Fowler KJ; Lockhart AC; Suresh R; Tan BR; Lim KH; Fields RC; Strasberg SM; Hawkins WG; DeNardo DG; Goedegebuure SP; Linehan DC
Lancet Oncol; 2016 May; 17(5):651-62. PubMed ID: 27055731
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous regression of pancreatic cancer with liver metastases.
Saade Lemus P; Anderson K; Smith M; Bullock A
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154349
[TBL] [Abstract][Full Text] [Related]
15. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
Lima CMSR
Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559
[No Abstract] [Full Text] [Related]
16. Metastatic pancreatic cancer: abdominal pain in a 22-year-old woman.
Roy BT; Roy RB
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26611479
[TBL] [Abstract][Full Text] [Related]
17. [A case of irinotecan-resistant colon cancer responding to chronotherapy with oxaliplatin, 5-FU, l-LV].
Sagawa T; Tsuji Y; Takayanagi N; Hirayama Y; Sakamaki S; Chiba H; Iyama S; Oku T; Sato Y; Takahashi M; Takayama T; Niitsu Y
Gan To Kagaku Ryoho; 2003 Apr; 30(4):537-43. PubMed ID: 12722689
[TBL] [Abstract][Full Text] [Related]
18. [FOLFIRINOX for Locally Advanced and Recurrent Pancreatic Cancer with UGT1A1 *6 and or UGT1A1*28 Polymorphisms-A Report of Two Cases].
Ishigame T; Kimura T; Tsukida S; Suzushino S; Muto M; Sato N; Kofunato Y; Okada R; Kenjo A; Shimura T; Marubashi S
Gan To Kagaku Ryoho; 2019 Apr; 46(4):754-756. PubMed ID: 31164525
[TBL] [Abstract][Full Text] [Related]
19. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
Fornaro L; Leone F; Vienot A; Casadei-Gardini A; Vivaldi C; Lièvre A; Lombardi P; De Luca E; Vernerey D; Sperti E; Musettini G; Satolli MA; Edeline J; Spadi R; Neuzillet C; Falcone A; Pasquini G; Clerico M; Passardi A; Buscaglia P; Meurisse A; Aglietta M; Brac C; Vasile E; Montagnani F
Clin Colorectal Cancer; 2019 Dec; 18(4):e394-e401. PubMed ID: 31564556
[TBL] [Abstract][Full Text] [Related]
20. Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer.
Byrne JD; Jajja MRN; O'Neill AT; Schorzman AN; Keeler AW; Luft JC; Zamboni WC; DeSimone JM; Yeh JJ
Cancer Chemother Pharmacol; 2018 Jun; 81(6):991-998. PubMed ID: 29603014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
